schliessen

Filtern

 

Bibliotheken

2.

Cost Differential of Chemotherapy for Solid Tumors.
by Nadeem, Hasan

Journal of oncology practice, March 2016, Vol.12(3), pp.e299-307, 251

4.

Big costs for little gain in ovarian cancer
by Hensley, Martee L

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 01 April 2011, Vol.29(10), pp.1230-2

5.

At what cost does a potential survival advantage of bevacizumab make sense for the primary treatment of ovarian cancer? A cost-effectiveness analysis.
by Cohn, David E

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, April 1, 2011, Vol.29(10), pp.1247-1251

15.

Using cost-effective intra-arterial chemotherapy to treat retinoblastoma in Chile.
by Ossandón, Diego

Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus, December 2014, Vol.18(6), pp.617-619

18.

Comparative cost-effectiveness of bevacizumab-irinotecan-fluorouracil versus irinotecan-fluorouracil in first-line metastatic colorectal cancer.
by Ruiz-Millo, Oreto

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, October 2014, Vol.20(5), pp.341-350

Recommended databases

Find more Articles matching your search terms in these recommended databases.

Filter electronic articles 143 Hits

Remove Filters